Abstract:There has also been a growing interest in the application of carbohydrates as pharmaceutical drugs in the field of invasive bacterial diseases, inflammatory diseases, and viral infections. Chemical oligosaccharide synthetic procedures often require tedious protection and deprotection steps. Enzymatic synthesis offers tremendous benefits because of its high regio- and stereoselectivities, stability, organic solvent compatibility, and low cost. Glycosyltransferase-catalyzed synthesis of carbohydrates has been recognized as one of the most practical approaches for its high efficiency and specificity under very mild conditions. The two main obstacles in the enzymatic synthesis of carbohydrates are the inadequate availability of glycosyltransferases and the high cost of sugar nucleotides, which serve as intermediates. Significant progress in the study of the enzymatic biosynthesis of complex carbohydrates has been made with developments in protein purification, molecular genetics, and new methods of enzymological analysis. Bioinformatics provide a large amount of putative candidates for carbohydrate active enzymes. The combined enzymatic and genetic approach has overcome formidable obstacles ubiquitous to the study of glycans, and has begun to yield new information that definitively addresses basic enzymological issues relevant to these complex carbohydrates. In fact, complex carbohydrates representing the glycan chain of gangliosides such as GT2, GM1, and GD1a were synthesized using glycosyltransferases. Although traditional cell-free enzymatic synthesis of oligosaccharides will continue to be used in laboratory scale synthesis, the future direction for large-scale preparation of complex oligosaccharides and polysaccharides will be whole-cell systems. Further development of these enzymatic methods will allow synthetic biochemists to create important molecular tools for biochemical, biophysical, and medical applications.

Mechanism-based probing, characterization, and inhibitor design of glycosidases and glycosyltransferases.

Enzymatic Synthesis of Oligosaccharides and Conversion to Glycolipids

Imaging of protein-specific glycosylation by glycan metabolic tagging and in situ proximity ligation.

Two-Photon Small Molecule Enzymatic Probes.

Universal Glycosyltransferase Continuous Assay for Uniform Kinetics and Inhibition Database Development and Mechanistic Studies Illustrated on ST3GAL1, C1GALT1, and FUT1

A Computational and Chemical Design Strategy for Manipulating Glycan‐Protein Recognition

Discovery of Non-Cysteine-Targeting Covalent Inhibitors by Activity-Based Proteomic Screening with a Cysteine-Reactive Probe.

Using High-Throughput Experiments To Screen N -Glycosyltransferases with Altered Specificities

Reseach on the engineering of glycosidases and glycosyltransferases

Engineering the enzyme toolbox to tailor glycosylation in small molecule natural products and protein biologics

Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology

Development of Tunable Mechanism-Based Carbasugar Ligands that Stabilize Glycoside Hydrolases through the Formation of Transient Covalent Intermediates

Structural and Mechanistic Investigations of Protein S-glycosyltransferases

Microplate-Based Enzymatic Activity Assay Protocol Powered by Activity-Based Probes

Synthesis of a fluorescent probe for measuring the activity of endo-β- N -acetylglucosaminidases recognizing hybrid-type N -glycans

A Kinetic Trapping Approach for Facile Access to 3F ax Neu5Ac and a Photo-Cross-Linkable Sialyltransferase Probe

From Mechanism-Based Retaining Glycosidase Inhibitors to Activity-Based Glycosidase Profiling

Affinity-Based Covalent Sialyltransferase Probes Enabled by Ligand-Directed Chemistry

A Bioorthogonal Precision Tool for human N-acetylglucosaminyltransferase V

Immobilized enzyme cascade for targeted glycosylation

Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology.